pLOG

2024-11-22

PatientsForce COO Wins 2024 Women Entrepreneur Elite Award, Showcasing Taiwan’s Healthcare Innovation

As global demand for healthcare continues to rise, third-party support systems in medical care have emerged as a key market trend, enabling broader access to innovative medicines. PatientsForce, serves as a leading provider of drug accessibility services for over 30 international pharmaceutical companies.Co-founder and COO of PatientsForce, Yi-Wen Wang, has been recognized with the 2024 Women Entrepreneur Elite Award by the Ministry of Economic Affairs’ Small and Medium Enterprise Administration. Her exceptional leadership and innovative approach to transforming healthcare services impressed the panel of judges, further underscoring Taiwan’s strength in healthcare innovation.

Integrated Health Ecosystem Leading the Revolution in Healthcare

According to the Ministry of Economic Affairs, Taiwan's healthcare market is steadily growing, with projections estimating it will exceed NT$2 trillion by 2030. The driving forces behind this growth not only include an aging population but also the widespread application of digital technologies in healthcare, such as AI, IoT, and data integration, which are reshaping industry models. The traditional single-payer medical insurance system is evolving into a more diversified payment market.

As a subsidiary of PatientsForce Healthcare, which focuses on medication support and management services, Media-Wind Health Strategy addresses the accessibility of new cancer treatments for Taiwanese patients through its proprietary PatientsForce platform. This innovative "treat-first, stage-later" approach helps alleviate the economic burden on patients while building a comprehensive integrated health ecosystem. The platform seamlessly connects healthcare services, data technologies, and long-term care needs, injecting new momentum into Taiwan's healthcare market.

The PatientsForce platform provides patients with full support from late-stage clinical trials to market promotion. This system not only helps international pharmaceutical companies quickly adapt to the Taiwanese market but also plays a crucial role in patient education and adherence management before and after National Health Insurance reimbursement, making it the preferred strategic partner for global pharmaceutical companies entering Taiwan.

"Taiwan's patient care market is currently facing challenges with limited manpower and financial resources, requiring innovative service models," emphasized PatientsForce Healthcare Group Chairman, Zhang Xiangxin. "In the global pharmaceutical supply chain, PatientsForce Healthcare Group has become a core partner for international pharmaceutical companies in Taiwan, offering services including pre-market clinical support, digital compliance management, and patient tracking with value-added services."

PatientsForce COO Wang Yiwen Wins 2024 Female Entrepreneur Excellence Award – "Legacy Transformation" Category

 

Digital Compliance and AI Customer Service Drive Innovation in Long-Term Care

"In every aspect of healthcare, we are committed to using technology and professional compliance systems to bridge the gap between patients and solutions," said COO Wang Yiwen. "Our goal is to become the critical hub that connects patients, healthcare providers, and treatment solutions."

2024 Female Entrepreneur Excellence Award Ceremony Held at Grand Hi-Lai Hotel, Taipei

On the 15th of this month, the 2024 Female Entrepreneur Excellence Award Ceremony took place at the Grand Hi-Lai Hotel in Nangang, where 13 outstanding female entrepreneurs were recognized for their exceptional leadership and achievements.

The high-value and high-barrier business model of PatientsForce positions it for immense growth potential, particularly in the rapidly expanding long-term care market across the Asia-Pacific region. "Patient support services not only have ESG and social impact innovation at their core but also feature a replicable and scalable business model," remarked the spokesperson. With the increasing demand for healthcare services in the growing "big health" industry, the company is capitalizing on policy support, technological innovation, and market demand, demonstrating strong integration capabilities and international competitiveness.